Protagenic Therapeutics, Inc.new (PTIX) stock
PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.36MP/E –Yield –
Protagenic Therapeutics, Inc.new price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Protagenic Therapeutics, Inc.new's price to book ratio was 0.8× on Oct 19, 2026, against 1.5× a year earlier. Over the last 3 years it ranged from 0.6× to 3.2×, with a median of 1.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.8× | −0.9 |
| 2024 | Apr 30, 2024 | 1.7× | +0.6 |
| 2023 | Dec 29, 2023 | 1.0× | +0.1 |
| 2022 | Dec 30, 2022 | 0.9× | −1.9 |
| 2021 | Oct 29, 2021 | 2.8× | – |
See a number that looks wrong?